First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure-Reference-Cited by-同舟云学术

First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure

Published:2022-08 Issue: Volume:204 Page:105361
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Muller Clotilde^ORCID,Tilloy Valentin,Frobert Emilie,Feghoul Linda,Garrigue Isabelle,Lepiller Quentin,Mirand Audrey,Sidorov Egor,Hantz Sébastien,Alain Sophie^ORCID

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference29 articles.

1. Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice;Alain;J. Antimicrob. Chemother.,2020

2. Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: benefits and limits of 3D analysis;Andouard;Antivir. Res.,2016

3. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artiﬁcial chromosome in Escherichia coli: a new approach for construction of HCMV mutants;Borst;J. Virol.,1999

4. The human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUL56 and pUL89;Borst;J. Virol.,2013

5. Original article Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity;Champier;Antivir. Ther.,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir;Infectious Disease Reports;2024-01-18

2. Anti-CMV therapy, what next? A systematic review;Frontiers in Microbiology;2023-11-20

3. Application of the ViroKey® SQ FLEX assay for detection of cytomegalovirus antiviral resistance;Journal of Clinical Virology;2023-10

4. Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation under 100-Day Letermovir Prophylaxis: A Real-World 1-Year Follow-Up Study;Viruses;2023-09-06

5. Identification of a leucine-zipper motif in pUL51 essential for HCMV replication and potential target for antiviral development;Antiviral Research;2023-09